GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **676 - 700** of **4050** in total

« First

‹ Prev

…

24

25

26

27

28

29

30

31

32

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▼
IgM	Patient 4	12	mild	G16579HJ	612
IgA	Patient 2	15	mild	G92022ML	608
IgA	Patient 2	24	mild	G58969RU	607
IgG	Patient 2	3	mild	G21460SG	607
IgM	Patient 3	11	mild	G43534QA	607
IgA	Patient 2	15	mild	G53168IY	606
IgA	Patient 2	24	mild	G29011JC	606
IgG	Patient 4	12	mild	G10133VD	606
IgG	Patient 2	3	mild	G18057VI	601
IgG	Patient 4	12	mild	G78074HX	597
IgA	Patient 2	3	mild	G25407RZ	596
IgA	Patient 2	24	mild	G10789DJ	594
IgA	Patient 2	24	mild	G43648DB	593
IgA	Patient 2	15	mild	G17140UR	590
IgA	Patient 2	15	mild	G39213VZ	586
IgA	Patient 2	15	mild	G71142DF	583
IgA	Patient 2	15	mild	G93351GM	580
IgG	Patient 2	24	mild	G10789DJ	580
IgA	Patient 4	12	mild	G86566MF	580
IgA	Patient 2	3	mild	G94576MN	579
IgA	Patient 1	22	moderate	G17140UR	578
IgM	Patient 3	4	mild	G17266GE	578
IgM	Patient 2	24	mild	G10133VD	576
IgA	Patient 2	3	mild	G17140UR	576
IgG	Patient 3	4	mild	G43648DB	575